AstraZeneca | Capitalisation Boursière



Market Capitalization Changement Date
AbbVie USD 306.72B 7.3B 2025-04
Alcon AG CHF 38.43B 3.71B 2024-12
Almirall EUR 1.77B 232.92M 2024-12
Amgen USD 155.38B 15.41B 2025-04
AstraZeneca GBP 162.31B 17.34B 2024-12
Biogen USD 17.08B 5.2B 2025-04
Bristol-Myers Squibb USD 100.66B 14.06B 2025-04
Eli Lilly USD 706.59B 26.28B 2025-04
Fresenius EUR 18.89B 438.78M 2024-12
Fresenius Medical Care EUR 12.98B 1.75B 2024-12
Galapagos EUR 1.76B 51.29M 2024-12
Genmab DKK 98.78B 8.42B 2024-12
Gilead Sciences USD 131.99B 16.9B 2025-04
GlaxoSmithKline GBP 55.81B 7.05B 2024-12
Indivior 1.28B 375.31M 2025-04
Lonza CHF 38.78B 3.36B 2024-12
Merck USD 196.74B 54.91B 2025-04
Novartis CHF 194.25B 18.5B 2024-12
Orion EUR 6.03B 927.26M 2024-12
Pfizer USD 126.33B 24.01B 2025-04
Philips EUR 23.05B 4.37B 2024-12
Regeneron Pharmaceuticals USD 60.81B 8.53B 2025-04
Sanofi EUR 118.41B 10.58B 2024-12



AstraZeneca Capitalisation Boursière - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.